Skip to main content

Published locations for The First Patient in the Veteran Affairs System to Receive Chimeric Antigen Receptors T-cell Therapy for Refractory Multiple Myeloma and the Role of Intravenous Immunoglobulin in the Prevention of Therapy-associated Infections

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. The First Patient in the Veteran Affairs System to Receive Chimeric Antigen Receptors T-cell Therapy for Refractory Multiple Myeloma and the Role of Intravenous Immunoglobulin in the Prevention of Therapy-associated Infections

User login

  • Reset your password
  • /content/first-patient-veteran-affairs-system-receive-chimeric-antigen-receptors-t-cell-therapy
  • /fedprac/article/270691/oncology/first-patient-veteran-affairs-system-receive-chimeric-antigen
  • /fedprac/avaho/article/270691/oncology/first-patient-veteran-affairs-system-receive-chimeric-antigen